Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Department of Genetic Disease Research, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka 545-8585, Japan.
Hum Mol Genet. 2021 Apr 26;30(3-4):213-225. doi: 10.1093/hmg/ddab034.
Primary cilia contain specific proteins to achieve their functions as cellular antennae. Ciliary protein trafficking is mediated by the intraflagellar transport (IFT) machinery containing the IFT-A and IFT-B complexes. Mutations in genes encoding the IFT-A subunits (IFT43, IFT121/WDR35, IFT122, IFT139/TTC21B, IFT140 and IFT144/WDR19) often result in skeletal ciliopathies, including cranioectodermal dysplasia (CED). We here characterized the molecular and cellular defects of CED caused by compound heterozygous mutations in IFT144 [the missense variant IFT144(L710S) and the nonsense variant IFT144(R1103*)]. These two variants were distinct with regard to their interactions with other IFT-A subunits and with the IFT-B complex. When exogenously expressed in IFT144-knockout (KO) cells, IFT144(L710S) as well as IFT144(WT) rescued both moderately compromised ciliogenesis and the abnormal localization of ciliary proteins. As the homozygous IFT144(L710S) mutation was found to cause autosomal recessive retinitis pigmentosa, IFT144(L710S) is likely to be hypomorphic at the cellular level. In striking contrast, the exogenous expression of IFT144(R1103*) in IFT144-KO cells exacerbated the ciliogenesis defects. The expression of IFT144(R1103*) together with IFT144(WT) restored the abnormal phenotypes of IFT144-KO cells. However, the coexpression of IFT144(R1103*) with the hypomorphic IFT144(L710S) variant in IFT144-KO cells, which mimics the genotype of compound heterozygous CED patients, resulted in severe ciliogenesis defects. Taken together, these observations demonstrate that compound heterozygous mutations in IFT144 cause severe ciliary defects via a complicated mechanism, where one allele can cause severe ciliary defects when combined with a hypomorphic allele.
初级纤毛包含特定的蛋白质,以实现其作为细胞天线的功能。纤毛蛋白运输是由包含 IFT-A 和 IFT-B 复合物的内纤毛运输 (IFT) 机制介导的。编码 IFT-A 亚基(IFT43、IFT121/WDR35、IFT122、IFT139/TTC21B、IFT140 和 IFT144/WDR19)的基因突变常导致骨骼纤毛病变,包括颅面外胚层发育不良 (CED)。我们在这里描述了 IFT144 复合杂合突变引起的 CED 的分子和细胞缺陷 [错义变体 IFT144(L710S)和无义变体 IFT144(R1103*)]。这两个变体在与其他 IFT-A 亚基和 IFT-B 复合物的相互作用方面存在明显差异。当在 IFT144 敲除 (KO) 细胞中外源表达时,IFT144(L710S)以及 IFT144(WT)均能挽救中度受损的纤毛发生和纤毛蛋白的异常定位。由于纯合 IFT144(L710S)突变被发现导致常染色体隐性视网膜色素变性,因此 IFT144(L710S)在细胞水平上可能是低功能的。相比之下,IFT144(R1103*)在 IFT144-KO 细胞中的表达加剧了纤毛发生缺陷。IFT144(R1103*)与 IFT144(WT)的共同表达恢复了 IFT144-KO 细胞的异常表型。然而,在 IFT144-KO 细胞中共同表达 IFT144(R1103*)和低功能 IFT144(L710S)变体,模拟复合杂合 CED 患者的基因型,导致严重的纤毛发生缺陷。总之,这些观察结果表明,IFT144 的复合杂合突变通过一种复杂的机制导致严重的纤毛缺陷,其中一个等位基因与低功能等位基因结合时会导致严重的纤毛缺陷。